DETECTION OF A KIT-ACTIVATING POINT MUTATION IN A C-KIT IMMUNOREACTIVE METASTATIC MELANOMA SUBSEQUENTLY TREATED WITH ADJUVANT IMATINIB THERAPY

  • Nash, J.
  • Lazar, A.
  • Prieto, V.
  • Papadopoulas, N.
  • Diwan, A.

  • UT MD Anderson Cancer Center, Houston, TX, USA

Journal of Cutaneous Pathology 34(1):p 82, January 2007.
Copyright © 2007 Blackwell Publishing Ltd.